TS

Tanuj Sharma

Active Director Director DIN 02279175
DIN 02279175 First appointment Aug 2008 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2008
Shareholding value •••• Premium profile

About Tanuj Sharma

Data last updated:

Tanuj Sharma is a Director at Sierra Pharmaceuticals Limited (since 2008). The company operates in Pharma. Sierra Pharmaceuticals Limited reported revenue of ₹1.38 Cr (FY 2024).

DIN 02279175
Primary Designation Director
Industry Pharma
First Appointment 01 Aug 2008
Oldest Company Age 27 yrs
Largest company Sierra Pharmaceuticals Limited · ₹1.38 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sierra Pharmaceuticals Limited U51397DL1999PLC100240
Director01 Aug 20081999₹1.38 Cr (FY 2024)Active

Board colleagues of Tanuj Sharma

Directorship timeline

Open interactive timeline →
Sierra Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Tanuj Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tanuj Sharma

Tanuj Sharma currently holds 1 directorship: Sierra Pharmaceuticals Limited (Director, since 01 Aug 2008, revenue ₹1.38 Cr (FY 2024)).

Tanuj Sharma was first appointed on 01 Aug 2008 as Director at Sierra Pharmaceuticals Limited.

The current boards of Tanuj Sharma's companies include Anil Sharma (Sierra Pharmaceuticals Limited), Archna Sharma (Sierra Pharmaceuticals Limited), Veena Sharma (Sierra Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available